ALDESLEUKIN (Proleukin) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

ALDESLEUKIN

What is the Trade Name for ALDESLEUKIN

Proleukin

What is the Indication for ALDESLEUKIN

  • INDICATIONS AND USAGE Proleukin ¬Æ (aldesleukin) is indicated for the treatment of adults with metastatic renal cell carcinoma (metastatic RCC). Proleukin is indicated for the treatment of adults with metastatic melanoma. Careful patient selection is mandatory prior to the administration of Proleukin. See ‚Äú CONTRAINDICATIONS ‚Äù, ‚Äú WARNINGS ‚Äù and ‚Äú PRECAUTIONS ‚Äù sections regarding patient screening, including recommended cardiac and pulmonary function tests and laboratory tests. Evaluation of clinical studies to date reveals that patients with more favorable ECOG performance status (ECOG PS 0) at treatment initiation respond better to Proleukin, with a higher response rate and lower toxicity (See ‚Äú CLINICAL PHARMACOLOGY ‚Äù section, ‚Äú CLINICAL STUDIES ‚Äù section and ‚Äú ADVERSE REACTIONS ‚Äù section). Therefore, selection of patients for treatment should include assessment of performance status. Experience in patients with ECOG PS >1 is extremely limited.

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]